SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-18-072108
Filing Date
2018-03-06
Accepted
2018-03-06 16:12:30
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-3 d454665df3.htm F-3 265528
2 EX-5.1 d454665dex51.htm EX-5.1 22651
3 EX-23.1 d454665dex231.htm EX-23.1 6317
4 GRAPHIC g454665g62p36.jpg GRAPHIC 4240
5 GRAPHIC g454665g66u18.jpg GRAPHIC 1232
6 GRAPHIC g454665g78s50.jpg GRAPHIC 2469
7 GRAPHIC g454665g79g20.jpg GRAPHIC 8551
  Complete submission text file 0001193125-18-072108.txt   318765
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: F-3 | Act: 33 | File No.: 333-223464 | Film No.: 18670008
SIC: 2834 Pharmaceutical Preparations